Women Benefit More From CRT-D, Likely Undertreated, CDRH Finds
This article was originally published in The Gray Sheet
Executive Summary
Women with heart failure, a left bundle block branch and heart-rhythm activity that typically does not qualify them for a top-level guideline recommendation to receive cardiac resynchronization therapy plus defibrillator clearly benefit from the therapy, while men do not, suggesting underuse, according to a study conducted by FDA device center researchers.